Recro Pharma, Inc.
USD2.09
-0.01 (-0.48%)
CEO
Geraldine Henwood
IPO Date
2014-03-07
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
NASDAQ
Country
US
Open
$2.07
Prev. Close
$2.10
Day Low
$2.00
Day High
$2.14
52W Low
$1.38
52W High
$3.29
Market Cap
$0.18B
Volume
0.14M
| 5,690 |
| $0.37 |
| 4 Dec 2023 | Lake Ryan David | Chief Financial Officer | F-InKind | Disposed | 1,197 | $0.37 |
| 2 Nov 2023 | Lake Ryan David | Chief Financial Officer | F-InKind | Disposed | 1,198 | $0.34 |
| 4 Oct 2023 | Lake Ryan David | Chief Financial Officer | F-InKind | Disposed | 1,198 | $0.46 |
| 5 Sept 2023 | Lake Ryan David | Chief Financial Officer | F-InKind | Disposed | 1,197 | $0.57 |
| 28 Aug 2023 | Reasons Bryan M. | director | P-Purchase | Acquired | 62,500 | $0.40 |
| 28 Aug 2023 | AWM Investment Company, Inc. | 10 percent owner | P-Purchase | Acquired | 140,000 | $0.40 |
| 28 Aug 2023 | AWM Investment Company, Inc. | 10 percent owner | P-Purchase | Acquired | 4,860,000 | $0.00 |
| 28 Aug 2023 | Weisman Wayne | director | P-Purchase | Acquired | 62,500 | $0.40 |